Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000185

Chairperson & CEO sold 1,614 shares at an average $584.59 ($943,521)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-09 Sale : show line 1 in the form 10b5-1 −494 $583.80 $288,398 325,563 I
2026-11-09 Sale : show line 2 in the form 10b5-1 −840 $584.70 $491,148 324,723 I
2026-11-09 Sale : show line 3 in the form 10b5-1 −280 $585.63 $163,975 324,443 I
Open-market sales · 1,614 sh · avg $584.59 · $943,521
Loading xslF345X06/primarydocument.xml…